Ebola | |||||
NEWS | |||||
Big Pharma chief who developed first Ebola shot breaks silence on COVID-19 In December, he heralded the first-ever Ebola vaccine to be approved by US regulators. Frazier, who has been seeking a successor, now says he ...
| |||||
Coronavirus breakthrough: Anti-Ebola drug is 'biggest step forward' since COVID erupted SOME NHS patients suffering from severe coronavirus infections are to be treated with an anti-Ebola drug after trials proved it can speed their recovery ...
| |||||
Powerful pharmaceutical company teams with nonprofit to fight to create vaccine to battle COVID-19 Researchers are utilizing the same technology used to fight another outbreak: Ebola. Dr. Swati Gupta, with the scientific research nonprofit IAVI, is one of ...
| |||||
Global Ebola Treatment Market 2020 Industry Statistics – Arbutus Biopharma, Chimerix ... The report on the global Ebola Treatment market includes segments by type & application, region, and major players. It explains the scope of different ...
| |||||
Kimmel Is Kinda Annoyed at How Trump's View of Golfing During an Outbreak Has Changed Since ... Now, while Ebola is extremely serious and horrific, the outbreak never posed a threat to Americans. Only four people in the US were infected, only one ...
| |||||
Pharma giant Merck just jumped into the coronavirus race with 2 vaccine candidates slated to start ... This platform worked for Ebola, leading Merck to produce the first US-approved Ebola vaccine. Merck said a coronavirus vaccine candidate should ...
| |||||
Britain to provide anti-viral drug remdesivir to some COVID-19 patients FILE PHOTO: An ampule of Ebola drug Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, ...
| |||||
Liberia: CPP Chairman to Reject Senatorial Election Deferment Beyond December 2020 ... the same way it happened in 2014 during Ebola Virus, but we will insistent, we will demand that the election does not go beyond December 2020," ...
| |||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
Tidak ada komentar:
Posting Komentar